Search research articles
Contact Us
Filters
Showing results (21-30 of 43) with videos related to
Page
of 5
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 19, 2015
Cancer Signature Investigation: ERBB2 (HER2)-Activating Mutation and Amplification-Positive Breast Carcinoma Mimicking Lung Primary
Jennifer Shih, Babar Bashir, Karen S Gustafson, et al.
JMIR Formative Research
|
November 10, 2023
Feasibility of a Text Messaging-Integrated and Chatbot-Interfaced Self-Management Program for Symptom Control in Patients With Gastrointestinal Cancer Undergoing Chemotherapy: Pilot Mixed Methods Study
Sameh Gomaa, James Posey, Babar Bashir, et al.
Therapeutic Advances in Urology
|
June 26, 2023
Bispecific PSMA antibodies and CAR-T in metastatic castration-resistant prostate cancer
Kevin K Zarrabi, Vivek Narayan, Patrick J Mille, et al.
Urologic Oncology
|
June 21, 2021
New and topics: enfortumab vedotin mechanisms of response and resistance in urothelial cancer - What do we understand so far?
Jean Hoffman-Censits, Kara Lombardo, David McConkey, et al.
Expert Review of Precision Medicine and Drug Development
|
May 24, 2021
GUCY2C as a biomarker to target precision therapies for patients with colorectal cancer
Amanda N Lisby, John C Flickinger, Babar Bashir, et al.
Cancer Biology & Therapy
|
February 11, 2020
APC-β-catenin-TCF signaling silences the intestinal guanylin-GUCY2C tumor suppressor axis
Erik S Blomain, Jeffrey A Rappaport, Amanda M Pattison, et al.
Investigational New Drugs
|
February 19, 2024
A phase 1b open-label study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of py314 in combination with pembrolizumab in patients with advanced renal cell carcinoma
Kathryn E Beckermann, Amita Patnaik, Ira Winer, et al.
Clinical Journal of Gastroenterology
|
April 8, 2023
Salvage endoscopic ultrasound-guided gastrojejunostomy as a bridge to definitive surgical therapy for duodenal adenocarcinoma presenting with duodenal stent obstruction
Tiffany Z Yu, Abishek Agnihotri, Richard Zheng, et al.
Human Pathology
|
February 5, 2019
Silencing the GUCA2A-GUCY2C tumor suppressor axis in CIN, serrated, and MSI colorectal neoplasia
Babar Bashir, Dante J Merlino, Jeffrey A Rappaport, et al.
Clinical and Translational Science
|
April 19, 2022
Pharmacokinetics of apixaban and tacrolimus or cyclosporine in kidney and lung transplant recipients
Holly Mansell, Ahmed Shoker, Jane Alcorn, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 43) with videos related to
Sort By:
Page
of 5
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 19, 2015
Cancer Signature Investigation: ERBB2 (HER2)-Activating Mutation and Amplification-Positive Breast Carcinoma Mimicking Lung Primary
Jennifer Shih, Babar Bashir, Karen S Gustafson, et al.
JMIR Formative Research
|
November 10, 2023
Feasibility of a Text Messaging-Integrated and Chatbot-Interfaced Self-Management Program for Symptom Control in Patients With Gastrointestinal Cancer Undergoing Chemotherapy: Pilot Mixed Methods Study
Sameh Gomaa, James Posey, Babar Bashir, et al.
Therapeutic Advances in Urology
|
June 26, 2023
Bispecific PSMA antibodies and CAR-T in metastatic castration-resistant prostate cancer
Kevin K Zarrabi, Vivek Narayan, Patrick J Mille, et al.
Urologic Oncology
|
June 21, 2021
New and topics: enfortumab vedotin mechanisms of response and resistance in urothelial cancer - What do we understand so far?
Jean Hoffman-Censits, Kara Lombardo, David McConkey, et al.
Expert Review of Precision Medicine and Drug Development
|
May 24, 2021
GUCY2C as a biomarker to target precision therapies for patients with colorectal cancer
Amanda N Lisby, John C Flickinger, Babar Bashir, et al.
Cancer Biology & Therapy
|
February 11, 2020
APC-β-catenin-TCF signaling silences the intestinal guanylin-GUCY2C tumor suppressor axis
Erik S Blomain, Jeffrey A Rappaport, Amanda M Pattison, et al.
Investigational New Drugs
|
February 19, 2024
A phase 1b open-label study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of py314 in combination with pembrolizumab in patients with advanced renal cell carcinoma
Kathryn E Beckermann, Amita Patnaik, Ira Winer, et al.
Clinical Journal of Gastroenterology
|
April 8, 2023
Salvage endoscopic ultrasound-guided gastrojejunostomy as a bridge to definitive surgical therapy for duodenal adenocarcinoma presenting with duodenal stent obstruction
Tiffany Z Yu, Abishek Agnihotri, Richard Zheng, et al.
Human Pathology
|
February 5, 2019
Silencing the GUCA2A-GUCY2C tumor suppressor axis in CIN, serrated, and MSI colorectal neoplasia
Babar Bashir, Dante J Merlino, Jeffrey A Rappaport, et al.
Clinical and Translational Science
|
April 19, 2022
Pharmacokinetics of apixaban and tacrolimus or cyclosporine in kidney and lung transplant recipients
Holly Mansell, Ahmed Shoker, Jane Alcorn, et al.
Page
of 5